We are analyzing https://link.springer.com/article/10.1007/s12307-012-0126-7.

Title:
Tumor Microenvironment and Myeloid-Derived Suppressor Cells | Cancer Microenvironment
Description:
Tumor progression has been demonstrated to be supported by chronic inflammatory conditions developed in the tumor microenvironment and characterized by the long-term secretion of various inflammatory soluble factors (including cytokines, chemokines, growth factors, reactive oxygen and nitrogen species, prostaglandins etc.) and strong leukocyte infiltration. Among leukocytes infiltrating tumors, myeloid-derived suppressor cells (MDSCs) represent one of the most important players mediating immunosuppression. These cells may not only strongly inhibit an anti-tumor immune reactions mediated by T cells but also directly stimulate tumorigenesis, tumor growth and metastasis by enhancing neoangiogenesis and creating a suitable environment for the metastatic formation. This review provides an overview of interactions between MDSCs and tumor cells leading to MDSC generation, activation and migration to the tumor site, where they can strongly enhance tumor progression. Better understanding of the MDSC-tumor interplay is critical for the development of new strategies of tumor immunotherapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, google, scholar, pubmed, cas, cells, cancer, suppressor, myeloidderived, immunol, tumor, cell, immune, res, rev, myeloid, microenvironment, factor, function, immunity, biol, inflammation, growth, antitumor, melanoma, human, nat, immunother, sevko, progression, clin, regulation, sinha, expression, chronic, factors, immunosuppression, activation, immunotherapy, suppression, research, umansky, metastasis, development, curr, semin, eur, med, role, mice,

Topics {✒️}

granulocyte-macrophage colony-stimulating factor month download article/chapter myeloid-derived suppressor cells cell-dependent antitumor immunity prevents anti-tumor response autocrine survival-growth factor enhancing t-cell responses preinvasive intra-abdominal tumor colony stimulating factors chemokine-mediated rapid turnover tumor-induced immune suppression inflammatory soluble factors immune-based cancer therapies regulate l-selectin expression trans retinoic acid enhances antitumor immunity tcr zeta-chain downregulation reduced interferon-alpha signaling macrophage-derived il-1 tgf-beta superfamily signaling tumor-induced tolerance membrane-bound tgf-beta 1 immune-mediated cancer control immature myeloid cells tumor microenvironment delays anti-tumor immunity full article pdf directly stimulate tumorigenesis melanoma tumor microenvironment tumour-infiltrating lymphocytes tumour cells promotes tumor eradication inhibiting antitumor immunity ostrand-rosenberg cxcr4 expression controls renal cell carcinoma drug-induced expression chronic inflammation paclitaxel promotes differentiation tumor-derived cytokines il-1β regulates author information authors myeloid-specific expression ret transgenic mice tyrosine kinase inhibitor article umansky viktor umansky tumor cells leading privacy choices/manage cookies immune cell function

Questions {❓}

Apte RN, Voronov E (2008) Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?
Klebanoff CA, Acquavella N, Yu Z et al (2011) Therapeutic cancer vaccines: are we there yet?
Maione P, Rossi A, Di Maio M et al (2009) Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?
Rivoltini L, Canese P, Huber V et al (2005) Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control?
Whiteside TL (2004) Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Tumor Microenvironment and Myeloid-Derived Suppressor Cells
         description:Tumor progression has been demonstrated to be supported by chronic inflammatory conditions developed in the tumor microenvironment and characterized by the long-term secretion of various inflammatory soluble factors (including cytokines, chemokines, growth factors, reactive oxygen and nitrogen species, prostaglandins etc.) and strong leukocyte infiltration. Among leukocytes infiltrating tumors, myeloid-derived suppressor cells (MDSCs) represent one of the most important players mediating immunosuppression. These cells may not only strongly inhibit an anti-tumor immune reactions mediated by T cells but also directly stimulate tumorigenesis, tumor growth and metastasis by enhancing neoangiogenesis and creating a suitable environment for the metastatic formation. This review provides an overview of interactions between MDSCs and tumor cells leading to MDSC generation, activation and migration to the tumor site, where they can strongly enhance tumor progression. Better understanding of the MDSC-tumor interplay is critical for the development of new strategies of tumor immunotherapy.
         datePublished:2012-12-16T00:00:00Z
         dateModified:2012-12-16T00:00:00Z
         pageStart:169
         pageEnd:177
         sameAs:https://doi.org/10.1007/s12307-012-0126-7
         keywords:
            Myeloid-derived suppressor cells
            Cancer
            Immunosuppression
            Tumor microenvironment
            Chronic inflammatory factors
            Tumorigenesis
            Cancer Research
            Oncology
            Immunology
            Cell Biology
            Biochemistry
            general
            Biomedicine
         image:
         isPartOf:
            name:Cancer Microenvironment
            issn:
               1875-2284
               1875-2292
            volumeNumber:6
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Viktor Umansky
               affiliation:
                     name:Skin Cancer Unit, German Cancer Research Center
                     address:
                        name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:Ruprecht-Karl University of Heidelberg
                     address:
                        name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Alexandra Sevko
               affiliation:
                     name:Skin Cancer Unit, German Cancer Research Center
                     address:
                        name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:Ruprecht-Karl University of Heidelberg
                     address:
                        name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Tumor Microenvironment and Myeloid-Derived Suppressor Cells
      description:Tumor progression has been demonstrated to be supported by chronic inflammatory conditions developed in the tumor microenvironment and characterized by the long-term secretion of various inflammatory soluble factors (including cytokines, chemokines, growth factors, reactive oxygen and nitrogen species, prostaglandins etc.) and strong leukocyte infiltration. Among leukocytes infiltrating tumors, myeloid-derived suppressor cells (MDSCs) represent one of the most important players mediating immunosuppression. These cells may not only strongly inhibit an anti-tumor immune reactions mediated by T cells but also directly stimulate tumorigenesis, tumor growth and metastasis by enhancing neoangiogenesis and creating a suitable environment for the metastatic formation. This review provides an overview of interactions between MDSCs and tumor cells leading to MDSC generation, activation and migration to the tumor site, where they can strongly enhance tumor progression. Better understanding of the MDSC-tumor interplay is critical for the development of new strategies of tumor immunotherapy.
      datePublished:2012-12-16T00:00:00Z
      dateModified:2012-12-16T00:00:00Z
      pageStart:169
      pageEnd:177
      sameAs:https://doi.org/10.1007/s12307-012-0126-7
      keywords:
         Myeloid-derived suppressor cells
         Cancer
         Immunosuppression
         Tumor microenvironment
         Chronic inflammatory factors
         Tumorigenesis
         Cancer Research
         Oncology
         Immunology
         Cell Biology
         Biochemistry
         general
         Biomedicine
      image:
      isPartOf:
         name:Cancer Microenvironment
         issn:
            1875-2284
            1875-2292
         volumeNumber:6
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Viktor Umansky
            affiliation:
                  name:Skin Cancer Unit, German Cancer Research Center
                  address:
                     name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:Ruprecht-Karl University of Heidelberg
                  address:
                     name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Alexandra Sevko
            affiliation:
                  name:Skin Cancer Unit, German Cancer Research Center
                  address:
                     name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:Ruprecht-Karl University of Heidelberg
                  address:
                     name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Microenvironment
      issn:
         1875-2284
         1875-2292
      volumeNumber:6
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Skin Cancer Unit, German Cancer Research Center
      address:
         name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
         type:PostalAddress
      name:Ruprecht-Karl University of Heidelberg
      address:
         name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:Skin Cancer Unit, German Cancer Research Center
      address:
         name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
         type:PostalAddress
      name:Ruprecht-Karl University of Heidelberg
      address:
         name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Viktor Umansky
      affiliation:
            name:Skin Cancer Unit, German Cancer Research Center
            address:
               name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:Ruprecht-Karl University of Heidelberg
            address:
               name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Alexandra Sevko
      affiliation:
            name:Skin Cancer Unit, German Cancer Research Center
            address:
               name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:Ruprecht-Karl University of Heidelberg
            address:
               name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
      name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
      name:Skin Cancer Unit, German Cancer Research Center, Heidelberg, Germany
      name:Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(357)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.19s.

LINK . SPRINGER . COM {}